"At Florida Cancer Affiliates, we are committed to providing you with the best and most advanced, complete care available. We begin by offering therapies proven to be effective and advanced diagnostic and treatment technologies. We continue by providing unprecedented access to new investigational drugs through clinical trials."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Novartis Pharmaceuticals
2
Clinical Trials at Florida Cancer Affiliates of Ocala
During the past decade, Florida Cancer Affiliates of Ocala conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss
2020-06-08
2024-06-19
Active, not recruiting
137
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Florida Cancer Affiliates of Ocala
According to Clinical.Site data, the most researched conditions in "Florida Cancer Affiliates of Ocala" are
"Non-Small Cell Lung Cancer" (1 trials) and "Triple Negative Breast Neoplasms" (1 trials). Many other conditions were trialed in "Florida Cancer Affiliates of Ocala" in a lesser frequency.
Clinical Trials Intervention Types at Florida Cancer Affiliates of Ocala
Most popular intervention types in "Florida Cancer Affiliates of Ocala" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Canakinumab" (1 trials), "Placebo" (1 trials), "alpelisib" (1 trials), "nab-paclitaxel" (1 trials) and "placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Florida Cancer Affiliates of Ocala
The vast majority of trials in "Florida Cancer Affiliates of Ocala" are
2 trials for "All" genders.
Clinical Trials Status at Florida Cancer Affiliates of Ocala
Currently, there are NaN active trials in "Florida Cancer Affiliates of Ocala".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Florida Cancer Affiliates of Ocala,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Florida Cancer Affiliates of Ocala, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Florida Cancer Affiliates of Ocala
Florida Cancer Affiliates of Ocala has several departments that took part in Clinical trials: "Ocala Oncology Center" - 116 trials